Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹14.6 LAccepted-AOC PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | ₹14.6 L | L1 | Accepted-AOC Details in notie |
| 2 | L1₹33.6 LAccepted-AOC | ₹33.6 L | L1 | Accepted-AOC Details in notice |
| Sl No | Description | Qty | Unit | Micron Pharmaceuticals L2 | M/s Pellucid Vetsciences L1 |
|---|---|---|---|---|---|
| 1.00 | FENBENDAZOLE AND PRAZIQUANTAL BOLUS Each tablet contain Fenbendazole IP 150mg and Praziquantel IP 50mg | 3,00,000 | 1 No | - | 5.81 ₹6.51 Lowest |
| 2.00 | MORANTEL CITRATE 594 mg | 2,00,000 | Bolus | - | 7.58 ₹8.49 Lowest |
| 3.00 | PYRANTAL PAMOATE
ORAL SUSPENSION 250 MG/ 5 ml | 48,300 | 10 ml | 27 ₹30.24 Lowest | - |
Tender Value
Refer Docs
EMD Value
₹15,000
Closing Date
13 Jan 2025, 5:00 pmClosed
Managing Director
KMSCL, THYCAUD
e-tender for the procurement of Deworming Medicines to the Animal Husbandry department for the year 2024-25
2024_KMSCL_717619_1
KMSCL/AHD-VET/RC/2024/030
Open Tender
Medicines
Item Wise
365 days
Thiruvananthapuram
Please refer tender document
16 documents required · 16 mandatory
₹29,500
Yes
₹15,000
Yes
1 Sept 2025
18 Dec 2024
16 Jan 2025
18 Dec 2024
13 Jan 2025
18 Dec 2024
18 Dec 2024 - 13 Jan 2025
FENBENDAZOLE AND PRAZIQUANTAL BOLUS Each tablet contain Fenbendazole IP 150mg and Praziquantel IP 50mg
MORANTEL CITRATE 594 mg
PYRANTAL PAMOATE ORAL SUSPENSION 250 MG/ 5 ml
Micron Pharmaceuticals (BID ID -2050775)
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .